CANCER GENETICS INC - COM (CGIX)

CUSIP: 13739U104

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM
Total 13F shares
2,305,610
Share change
+483,724
Total reported value
$4,037,000
Price per share
$1.75
Number of holders
26
Value change
+$834,991
Number of buys
9
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 13739U104?
CUSIP 13739U104 identifies CGIX - CANCER GENETICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CANCER GENETICS INC - COM (CGIX) as of Q3 2016

As of 30 Sep 2016, CANCER GENETICS INC - COM (CGIX) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,305,610 shares. The largest 10 holders included PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, Anson Funds Management LP, Fairbanks Capital Management, Inc., RENAISSANCE TECHNOLOGIES LLC, SABBY MANAGEMENT, LLC, PANAGORA ASSET MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, and EAGLE GLOBAL ADVISORS LLC. This page lists 26 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.